Sonendo (SONX) Competitors $1.15 0.00 (0.00%) As of 07/3/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock SONX vs. IVF, AVGR, NUWE, DYNT, CUTR, NAYA, BIOL, STSS, HSDT, and IONMShould you be buying Sonendo stock or one of its competitors? The main competitors of Sonendo include INVO Fertility (IVF), Avinger (AVGR), Nuwellis (NUWE), Dynatronics (DYNT), Cutera (CUTR), NAYA Biosciences (NAYA), BIOLASE (BIOL), Sharps Technology (STSS), Helius Medical Technologies (HSDT), and Assure (IONM). These companies are all part of the "medical equipment" industry. Sonendo vs. Its Competitors INVO Fertility Avinger Nuwellis Dynatronics Cutera NAYA Biosciences BIOLASE Sharps Technology Helius Medical Technologies Assure Sonendo (NYSE:SONX) and INVO Fertility (NASDAQ:IVF) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends. Do insiders and institutionals hold more shares of SONX or IVF? 28.7% of Sonendo shares are owned by institutional investors. Comparatively, 12.0% of INVO Fertility shares are owned by institutional investors. 7.9% of Sonendo shares are owned by insiders. Comparatively, 0.6% of INVO Fertility shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more risk & volatility, SONX or IVF? Sonendo has a beta of 1.5, indicating that its share price is 50% more volatile than the S&P 500. Comparatively, INVO Fertility has a beta of 2.04, indicating that its share price is 104% more volatile than the S&P 500. Which has better valuation and earnings, SONX or IVF? INVO Fertility has lower revenue, but higher earnings than Sonendo. INVO Fertility is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSonendo$44.40M0.01-$60.92M-$59.12-0.02INVO Fertility$6.53M0.29-$9.10M-$34.06-0.03 Is SONX or IVF more profitable? Sonendo has a net margin of -92.74% compared to INVO Fertility's net margin of -377.73%. INVO Fertility's return on equity of 0.00% beat Sonendo's return on equity.Company Net Margins Return on Equity Return on Assets Sonendo-92.74% -184.01% -68.60% INVO Fertility -377.73%N/A -88.18% Does the media favor SONX or IVF? In the previous week, INVO Fertility had 1 more articles in the media than Sonendo. MarketBeat recorded 1 mentions for INVO Fertility and 0 mentions for Sonendo. Sonendo's average media sentiment score of 0.00 equaled INVO Fertility'saverage media sentiment score. Company Overall Sentiment Sonendo Neutral INVO Fertility Neutral SummarySonendo and INVO Fertility tied by winning 6 of the 12 factors compared between the two stocks. Get Sonendo News Delivered to You Automatically Sign up to receive the latest news and ratings for SONX and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SONX vs. The Competition Export to ExcelMetricSonendoDental equipment & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$493K$420K$5.56B$20.68BDividend YieldN/AN/A5.22%3.71%P/E Ratio-0.02N/A27.6928.10Price / Sales0.010.01386.4636.76Price / CashN/AN/A36.8922.53Price / Book0.010.018.034.58Net Income-$60.92M-$40.78M$3.18B$985.54M7 Day PerformanceN/AN/A2.93%2.79%1 Month Performance-8.00%-8.00%1.72%4.37%1 Year PerformanceN/AN/A34.39%15.08% Sonendo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SONXSonendoN/A$1.15flatN/AN/A$493K$44.40M-0.02250IVFINVO FertilityN/A$0.84-4.0%N/AN/A$1.90M$6.53M-0.0210Gap UpAVGRAvingerN/A$0.47flatN/AN/A$1.57M$7.65M-0.0470NUWENuwellis1.822 of 5 stars$0.23+4.9%$17.00+7,249.8%-95.1%$960K$8.74M-0.0170News CoveragePositive NewsDYNTDynatronics0.2895 of 5 stars$0.08flatN/A-64.6%$876K$33.60M-0.10200News CoverageGap DownHigh Trading VolumeCUTRCuteraN/A$0.04-63.9%$3.00+7,592.3%-97.0%$787K$155.21M-0.01460Gap DownHigh Trading VolumeNAYANAYA BiosciencesN/A$0.88-4.1%$24.00+2,627.6%N/A$586K$6.23M0.0010High Trading VolumeBIOLBIOLASE1.0144 of 5 stars$0.01+13.2%$1.20+9,900.0%-88.5%$401K$48.83M0.00160News CoverageSTSSSharps Technology0.0976 of 5 stars$5.54+1.7%N/AN/A$290KN/A0.003Gap UpHSDTHelius Medical Technologies0.5293 of 5 stars$8.60-5.5%N/A-98.6%$100K$520K-0.1830Stock SplitGap DownHigh Trading VolumeIONMAssureN/A$0.03-39.3%N/A-99.5%$91K$149K0.00130Gap Down Related Companies and Tools Related Companies IVF Alternatives AVGR Alternatives NUWE Alternatives DYNT Alternatives CUTR Alternatives NAYA Alternatives BIOL Alternatives STSS Alternatives HSDT Alternatives IONM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SONX) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s BIGGEST setup yet.After another undefeated quarter, “Market Wizard” Larry Benedict is sounding the alarm on a $194 trillion mark...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonendo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonendo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
